Teckro

About:

Teckro is a life science technology company that is rethinking every element of clinical research.

Website: http://teckro.com/

Twitter/X: teckroofficial

Top Investors: Enterprise Ireland, Sands Capital Ventures, Founders Fund, Section 32, Northpond Ventures

Description:

Teckro is a life science technology company that is rethinking every element of clinical research - the people, the processes, and the technologies used. By making it possible for all relevant information to be instantly accessible to every active member of a clinical trial and for the entire study teams to be connected effortlessly, Teckro is broadening the possibilities of what they can achieve. Teckro's solutions result in quicker development of drugs and treatments for the world’s most complex diseases. The company was founded in 2015 and is based in Limerick, Ireland with offices in Dublin and Nashville.

Total Funding Amount:

$66M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)teckro.com

Founders:

Gary Hughes, Jacek Skrzypiec, Nigel Hughes

Number of Employees:

51-100

Last Funding Date:

2021-11-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai